Technical Analysis for MRSN - Mersana Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 18.41 -4.96% -0.96
MRSN closed down 4.96 percent on Tuesday, June 19, 2018, on 1.27 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical MRSN trend table...

Date Alert Name Type % Chg
Jun 19 50 DMA Support Bullish 0.00%
Jun 19 MACD Bullish Centerline Cross Bullish 0.00%
Jun 19 Wide Bands Range Expansion 0.00%
Jun 18 Calm After Storm Range Contraction -4.96%
Jun 18 Multiple of Ten Bearish Other -4.96%
Jun 18 Inside Day Range Contraction -4.96%
Jun 18 Wide Bands Range Expansion -4.96%
Jun 15 50 DMA Support Bullish -7.39%
Jun 15 MACD Bullish Signal Line Cross Bullish -7.39%
Jun 15 Wide Range Bar Range Expansion -7.39%

Older signals for MRSN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mersana Therapeutics, Inc. is a United States-based biotechnology company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies. XMT-1522 is based on its Dolaflexin platform and has over 15 auristatin molecules per antibody. XMT-1522 is in Phase I clinical trial for various indications of cancers. XMT-1536 is in pre-clinical development.
Is MRSN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.96
52 Week Low 12.45
Average Volume 119,727
200-Day Moving Average 16.9074
50-Day Moving Average 17.566
20-Day Moving Average 18.3935
10-Day Moving Average 16.729
Average True Range 1.6324
ADX 16.05
+DI 32.76
-DI 28.08
Chandelier Exit (Long, 3 ATRs ) 19.0628
Chandelier Exit (Short, 3 ATRs ) 18.6172
Upper Bollinger Band 23.9436
Lower Bollinger Band 12.8434
Percent B (%b) 0.5
BandWidth 60.348493
MACD Line 0.0201
MACD Signal Line -0.1518
MACD Histogram 0.1719
Fundamentals Value
Market Cap 418.15 Million
Num Shares 22.7 Million
EPS -16.23
Price-to-Earnings (P/E) Ratio -1.13
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.16
Resistance 3 (R3) 22.21 21.01 21.54
Resistance 2 (R2) 21.01 20.06 20.99 21.33
Resistance 1 (R1) 19.71 19.47 19.11 19.66 21.12
Pivot Point 18.51 18.51 18.21 18.49 18.51
Support 1 (S1) 17.21 17.56 16.61 17.16 15.70
Support 2 (S2) 16.01 16.97 15.99 15.49
Support 3 (S3) 14.71 16.01 15.29
Support 4 (S4) 14.66